Zakharova I A, Kartasheva E A, Makhmutov V Iu
Vestn Oftalmol. 1994 Apr-Jun;110(2):7-8.
Intravascular irradiation of the blood with He-Ne laser at a wavelength 680 nm and 0.5 mWt power via Leukocyte light-guide introduced into one of the cubital veins was used in the treatment of patients with primary glaucoma. Treatment efficacy was assessed from changes in vision acuity, visual field, angioscotomas, blind spot, ophthalmic tone, and tonographic parameters. Treatment efficacies of traditional therapy and the suggested exposure were compared. Endovascular laser therapy exerted a more marked effect as regarded improvement of vision acuity, decrease of the blind spot and angioscotomas, reduction of intraocular pressure, and improvement of tonographic parameters. This recommends such exposure for the treatment of primary glaucoma patients in complex with other treatment modalities.
通过插入肘静脉之一的白细胞光导，以波长680纳米、功率0.5毫瓦的氦氖激光对血液进行血管内照射，用于治疗原发性青光眼患者。根据视力、视野、血管暗点、盲点、眼压和眼压描记参数的变化评估治疗效果。比较了传统疗法和建议照射的治疗效果。就提高视力、减小盲点和血管暗点、降低眼压以及改善眼压描记参数而言，血管内激光疗法产生了更显著的效果。这表明这种照射方式可与其他治疗方式联合用于治疗原发性青光眼患者。
